Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESOS: Tralokinumab in adults with asthma inadequately controlled on inhaled corticosteroids
2015-000857-19Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Tralokinumab with Placebo (2 arms). Primary endpoint: Airway submucosal eosinophils change. Started May 2015; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-000857-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000857-19.